Accuray Buys TomoTherapy To Create 'Premier' Radiation Oncology Company
Radiosurgery device maker Accuray is acquiring radiation therapy developer TomoTherapy for $277 million in cash and stock to form “the premier radiation oncology company,” according to the firms.